+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma



Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma



Genes Chromosomes and Cancer 45(1): 47-60



Detailed analysis of mechanisms of genetic loss for specific tumor suppressor genes (TSGs; e.g., RB1, APC and NF1) indicates that TSG inactivation can occur by allelic loss of heterozygosity (LOH), without any alteration in DNA copy number. However, the role and prevalence of such events in the pathogenesis of specific malignancies remains to be established on a genome-wide basis. We undertook a detailed molecular assessment of chromosomal defects in a panel of nine cell lines derived from primary medulloblastomas, the most common malignant brain tumors of childhood, by parallel genome-wide assessment of LOH (allelotyping) and copy number aberrations (comparative genomic hybridization and fluorescence in situ hybridization). The majority of genetic losses observed were detected by both copy number and LOH methods, indicating they arise through the physical deletion of chromosomal material. However, a significant proportion of losses (17/42, 40%) represented regions of allelic LOH without any associated copy number reduction; these events involved both whole chromosomes (10/17) and sub-chromosomal regions (7/17). Using this approach, we identified medulloblastoma-characteristic alterations, e.g., isochromosome for 17q, MYC amplification and losses on chromosomes 10, 11, and 16, alongside novel regions of genetic loss (e.g., 10q21.1-26.3, 11q24.1-qter). This detailed genetic characterization of the majority of medulloblastoma cell lines provides important precedent for the widespread involvement of copy number-neutral genetic losses in medulloblastoma and demonstrates that combined assessment of copy number aberrations and LOH will be necessary to accurately determine the contribution of chromosomal defects to tumor development.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011875250

Download citation: RISBibTeXText

PMID: 16149064

DOI: 10.1002/gcc.20262


Related references

High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma. Diagnostic Molecular Pathology 22(2): 76-84, 2013

Genome-wide copy number analysis using copy number inferring tool (CNIT) and DNA pooling. Human Mutation 29(8): 1055-1062, 2008

Combined analysis of genome-wide expression and copy number profiles to identify key altered genomic regions in cancer. Bmc Genomics 13(Suppl. 5): S5, 2012

Genome-wide copy number analysis on GeneChip platform using copy number analyzer for affymetrix GeneChip 2.0 software. Methods in Molecular Biology 396: 185-206, 2007

Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma. Journal of Oral Pathology and Medicine 43(1): 20-27, 2014

Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling. Journal of Neuro-Oncology 107(1): 37-49, 2012

Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays. Current Medicinal Chemistry 19(22): 3739-3747, 2012

A genome-wide single nucleotide polymorphism and copy number variation analysis for number of piglets born alive. Bmc Genomics 20(1): 321, 2019

Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene 22(27): 4281-4286, 3 July, 2003

ACNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations. Plos one 12(12): E0189334, 2017

Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors. Cancer 113(6): 1453-1461, 2008

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome. Plos one 11(2): E0148972, 2016

A significant risk locus on 19q13 for bipolar disorder identified using a combined genome-wide linkage and copy number variation analysis. Biodata Mining 8: 42, 2015

High-resolution copy number arrays in cancer and the problem of normal genome copy number variation. Genes Chromosomes and Cancer 47(11): 933-938, 2008

Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. American Journal of Human Genetics 80(6): 1037-1054, 2007